Table 3. Outcome Measures.
| Outcome | No./Total No. (%) of Participants | Odds Ratio (95% CI) or Estimated (SE) | |||
|---|---|---|---|---|---|
| 6 mo: Baseline | 6-mo: Baseline to After Treatment | 12 mo: After Treatment to End of Follow-upa | Difference at End of Active Treatment | Difference at Final Follow-up | |
| No. of suicide attemptsb | |||||
| IGST | 0.30 (0.10-0.91)c | 0.65 (0.12-3.36) | |||
| 0 | 16/87 (18.4) | 51/65 (78.5) | 52/58 (89.7) | ||
| 1 | 41/87 (47.1) | 9/65 (13.9) | 6/58 (10.3) | ||
| ≥2 | 30/87 (34.5) | 5/65 (7.7) | 0/58 (0) | ||
| DBT | |||||
| 0 | 15/86 (17.4) | 65/72 (90.3) | 66/71 (93.0) | ||
| 1 | 42/86 (48.8) | 6/72 (8.3) | 3/71 (4.2) | ||
| ≥2 | 29/86 (33.7) | 1/72 (1.4) | 2/71 (2.8) | ||
| No. of NSSI episodesb | |||||
| IGST | 0.32 (0.13-0.77)c | 0.60 (0.24-1.52) | |||
| 0 | 4/87 (4.6) | 26/65 (40.0) | 30/58 (51.7) | ||
| 1-3 | 20/87 (23.0) | 20/65 (30.8) | 22 (37.9) | ||
| 4-6 | 12/87 (13.8) | 8/65 (12.3) | 1/58 (1.7) | ||
| ≥7 | 51/87 (58.6) | 11/65 (16.9) | 5/58 (8.6) | ||
| DBT | |||||
| 0 | 6/86 (7.0) | 41/72 (56.9) | 44/71 (62.0) | ||
| 1-3 | 20/86 (23.3) | 21/72 (29.2) | 19/71 (26.8) | ||
| 4-6 | 9/86 (10.5) | 3/72 (4.2) | 4/71 (5.6) | ||
| ≥7 | 51/86 (59.3) | 7/72 (9.7) | 4/71 (5.6) | ||
| No. of self-harm episodesb | |||||
| IGST | 0.33 (0.14-0.78)c | 0.58 (0.23-1.46) | |||
| 0 | 0/87 (0) | 24/65 (36.9) | 28/58 (48.3) | ||
| 1-3 | 19/87 (21.8) | 22/65 (33.9) | 24/58 (41.4) | ||
| 4-9 | 19/87 (21.8) | 11/65 (16.9) | 2/58 (3.5) | ||
| ≥10 | 49/87 (53.5) | 8/65 (12.3) | 4/58 (6.9) | ||
| DBT | |||||
| 0 | 0/86 (0) | 39/72 (54.2) | 44 (62.0) | ||
| 1-3 | 18/86 (20.9) | 23/72 (31.9) | 18/71 (25.4) | ||
| 4-9 | 22/86 (25.6) | 3/72 (4.2) | 7/71 (9.9) | ||
| ≥10 | 46/86 (53.5) | 7/72 (9.7) | 2/71 (2.8) | ||
Abbreviations: DBT, dialectical behavior therapy; IGST, individual and group supportive therapy; NSSI, nonsuicidal self-injury.
a
Outcomes analyzed through a piecewise linear HLM with 2 phases of change: baseline through the end of active treatment (6 months) and end of active treatment through follow-up (12 months). Baseline values are based on the past 6 months.
b
Outcomes analyzed through an ordinal mixed-effects model that controlled for baseline level of severity. Descriptive data for suicide attempts, nonsuicidal self-injury, and self-harm episodes represent observed ordinal categories.
c
P < .05.